A detailed history of Cnb Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cnb Bank holds 7,249 shares of BMY stock, worth $429,648. This represents 0.17% of its overall portfolio holdings.

Number of Shares
7,249
Previous 7,749 6.45%
Holding current value
$429,648
Previous $321,000 16.82%
% of portfolio
0.17%
Previous 0.16%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$39.66 - $51.75 $19,830 - $25,875
-500 Reduced 6.45%
7,249 $375,000
Q2 2024

Aug 08, 2024

SELL
$40.25 - $52.99 $33,085 - $43,557
-822 Reduced 9.59%
7,749 $321,000
Q1 2024

May 02, 2024

SELL
$47.98 - $54.4 $20,631 - $23,392
-430 Reduced 4.78%
8,571 $464,000
Q4 2023

Jan 31, 2024

SELL
$48.48 - $57.85 $5,090 - $6,074
-105 Reduced 1.15%
9,001 $461,000
Q3 2023

Nov 02, 2023

BUY
$57.89 - $64.73 $18,351 - $20,519
317 Added 3.61%
9,106 $528,000
Q2 2023

Aug 08, 2023

BUY
$63.71 - $70.74 $31,154 - $34,591
489 Added 5.89%
8,789 $562,000
Q1 2023

May 10, 2023

SELL
$65.71 - $74.53 $9,856 - $11,179
-150 Reduced 1.78%
8,300 $575,000
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $10,956 - $12,974
-160 Reduced 1.86%
8,450 $607,000
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $56 - $33,348
-434 Reduced 4.8%
8,610 $612,000
Q2 2022

Aug 19, 2022

SELL
$72.62 - $79.98 $427,150 - $470,442
-5,882 Reduced 39.41%
9,044 $696,000
Q2 2022

Aug 10, 2022

BUY
$72.62 - $79.98 $396,868 - $437,090
5,465 Added 57.76%
14,926 $1.15 Million
Q1 2022

Apr 13, 2022

SELL
$61.48 - $73.72 $29,203 - $35,017
-475 Reduced 4.78%
9,461 $691,000
Q4 2021

Jan 31, 2022

SELL
$53.63 - $62.52 $9,814 - $11,441
-183 Reduced 1.81%
9,936 $620,000
Q3 2021

Nov 02, 2021

SELL
$59.17 - $69.31 $24,023 - $28,139
-406 Reduced 3.86%
10,119 $599,000
Q2 2021

Jul 29, 2021

BUY
$61.91 - $67.42 $10,524 - $11,461
170 Added 1.64%
10,525 $703,000
Q1 2021

May 03, 2021

SELL
$59.34 - $66.74 $3,560 - $4,004
-60 Reduced 0.58%
10,355 $654,000
Q4 2020

Jan 27, 2021

SELL
$57.74 - $65.43 $23,557 - $26,695
-408 Reduced 3.77%
10,415 $646,000
Q3 2020

Oct 26, 2020

SELL
$57.43 - $63.64 $174,070 - $192,892
-3,031 Reduced 21.88%
10,823 $653,000
Q2 2020

Jul 14, 2020

SELL
$54.82 - $64.09 $49,283 - $57,616
-899 Reduced 6.09%
13,854 $815,000
Q1 2020

May 13, 2020

SELL
$46.4 - $67.43 $94,795 - $137,759
-2,043 Reduced 12.16%
14,753 $822,000
Q4 2019

Jan 27, 2020

BUY
$49.21 - $64.19 $75,537 - $98,531
1,535 Added 10.06%
16,796 $1.08 Million
Q3 2019

Nov 04, 2019

SELL
$42.77 - $50.71 $97,686 - $115,821
-2,284 Reduced 13.02%
15,261 $774,000
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $58,630 - $64,832
-1,314 Reduced 6.97%
17,545 $796,000
Q1 2019

Apr 29, 2019

BUY
$45.12 - $53.8 $68,447 - $81,614
1,517 Added 8.75%
18,859 $900,000
Q4 2018

Feb 06, 2019

BUY
$48.76 - $63.23 $35,692 - $46,284
732 Added 4.41%
17,342 $902,000
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $26,601 - $30,004
-482 Reduced 2.82%
16,610 $1.03 Million
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $6,872 - $8,565
-136 Reduced 0.79%
17,092 $946,000
Q1 2018

May 11, 2018

BUY
$59.92 - $68.98 $103,541 - $119,197
1,728 Added 11.15%
17,228 $1.09 Million
Q4 2017

Feb 20, 2018

BUY
$59.94 - $65.35 $929,070 - $1.01 Million
15,500
15,500 $950,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cnb Bank Portfolio

Follow Cnb Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cnb Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cnb Bank with notifications on news.